SBN
Click for more information
0.00% 0.0¢ sun biomedical limited

It won't be the only focusFrom the company update on 20...

  1. skattie
    261 Posts.
    clock Created with Sketch.
    19/11/13
    09:45
    Post #: 12588341
    It won't be the only focus

    From the company update on 20 august:

    "Exploit the best opportunities from its current biotechnology intellectual property, specifically the
    “Oraline” series.
    Add additional biotechnology assets and potentially attract high calibre, experienced biotechnology
    talent to the Company in the process."

    SBN Price at posting: 1.1¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LYC Lynas eyes first dysprosium, terbium HREE production in CY25
right-arrow Created with Sketch.
NEWS Tenant turnover: Reducing costs and revenue-loss
right-arrow Created with Sketch.
NIM Nimy extends sulphide targets at Mons with new anomalies identified
right-arrow Created with Sketch.
PDN Paladin flags up to 4.5Mlbs of uranium production in FY25 guidance
right-arrow Created with Sketch.
PH2 Pure Hydrogen to supply hydrogen-fuelled garbage truck to City of Newcastle
right-arrow Created with Sketch.
3DP Pointerra wins US$1.63M from US Dept of Energy to model climate change scenarios
right-arrow Created with Sketch.
watchlist Created with Sketch. Add SBN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.